This is the program for the 2010 Joint Statistical Meetings in Vancouver, British Columbia.
Abstract Details
|
Activity Number:
|
645
|
|
Type:
|
Invited
|
|
Date/Time:
|
Thursday, August 5, 2010 : 10:30 AM to 12:20 PM
|
|
Sponsor:
|
Biopharmaceutical Section
|
| Abstract - #305987 |
|
Title:
|
Multiplicity in Clinical Trials: A European Perspective
|
|
Author(s):
|
Norbert Benda*+ and Joachim Roehmel
|
|
Companies:
|
BfArM and Institute for Prevention Research and Social Medicine
|
|
Address:
|
, , ,
|
|
Keywords:
|
Clinical Trials ;
Multiplicity ;
Europe
|
|
Abstract:
|
Soon after the ICH E9 Biostatistical guideline has been released end of 1998, European regulators required further and more detailed information on several key methodological issues that were discussed. Among these issues were "role of meta-analysis in the licensing process", "non-inferiority", and "multiplicity issues". It was the general feeling that the guidance provided by the ICH E9 document should be supplemented in order to facilitate a more effective regulatory review of new submissions. Statisticians employed by European agencies have been rare even today. The supplementary guidances therefore also aimed at strengthening the methodological basis within the 16 national agencies. I will touch briefly the main topics from the CPMP Points-to-Consider document "Multiplicity Issues in Clinical Trials" and will then address new
|
The address information is for the authors that have a + after their name.
Authors who are presenting talks have a * after their name.
Back to the full JSM 2010 program
|
2010 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.